
Telmitic H 40mg/12.5mg Tablet
Marketer
Cardiatic Care
Salt Composition
Telmisartan (40mg) + Hydrochlorothiazide (12.5mg)
Overview Telmitic H 40mg/12.5mg Tablet
Each Telmitic H 40mg/12.5mg tablet combines two blood pressure-regulating medications, ideal when a single drug proves insufficient. This combination lowers blood pressure, reducing future heart attack and stroke risk. This medication can be taken with or without food; dosage is individualized and should be taken consistently daily. Continue treatment as directed by your physician. The formulation includes a diuretic, increasing urination; therefore, avoid taking it within four hours of bedtime. Consistent use, even feeling well, is crucial for optimal benefit; stopping increases heart attack/stroke risk. Dizziness is the most common side effect; fatigue, nausea, breathlessness, and altered heartbeat are also possible. Increased urination is expected, not a side effect. While infrequent, other side effects may occur. Review the accompanying patient information leaflet and report bothersome or persistent side effects to your doctor; dosage adjustment or alternative medication may be considered. Avoid potassium supplements or salt substitutes unless medically advised. Consult your physician before use if pregnant, breastfeeding, or with kidney, liver, heart, or diabetic conditions. Alcohol consumption may exacerbate blood pressure reduction and side effects.
Uses of Telmitic H 40mg/12.5mg Tablet
Managing Elevated Blood Pressure
Major Benefits of Telmitic H 40mg/12.5mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmitic H 40mg/12.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Telmitic H 40mg/12.5mg Tablet:
- Fatigue
- Dizziness
- Nausea
- Decreased magnesium level in blood
How to use Telmitic H 40mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmitic H 40mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
How Telmitic H 40mg/12.5mg Tablet works:
Each Telmitic H 40mg/12.5mg tablet contains a dual-drug formulation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Telmitic H 40mg/12.5mg tablets is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Telmitic H 40mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Telmitic H 40mg/12.5mg tablets are likely incompatible. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Telmitic H 40mg/12.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmitic H 40mg/12.5mg tablets, as dose modification may be necessary. Medical advice is recommended. Telmitic H 40mg/12.5mg tablets are not advised for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Telmitic H 40mg/12.5mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telmitic H 40mg/12.5mg Tablet :
Should you forget to take a Telmitic H 40mg/12.5mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmitic H 40mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
